Frederick G. Vogt - Interim CEO & General Counsel, Director at Iovance Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO & General Counsel, Director
Stock Symbol
IOVA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Frederick G. Vogt - trading volume in the past year for Iovance Biotherapeutics, Inc.

Holdings reported by Frederick G. Vogt for Iovance Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 250K $758K $4.04 Sep 2, 2025 Direct Common stock
Common Stock 405K $712K $1.76 Jun 2, 2025 Direct

Transactions reported by Frederick G. Vogt for Iovance Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.